REVELATION BIOSCIENCES, INC. (REVB): Nasdaq/NYSE listing notice — Revelation Biosciences receives Nasdaq bid price deficiency notice

REVELATION BIOSCIENCES, INC.

Nasdaq notified REVB on Aug 8, 2023 of noncompliance with minimum $1.00 bid price rule for 30 consecutive business days.
Company has a 180-day grace period until Feb 5, 2024 to regain compliance; common stock must close at $1.00+ for 10 consecutive days.
If not cured, may be eligible for an additional 180-day extension pending meeting other listing standards and reverse stock split if needed.
Noncompliance has no immediate impact on trading; stock continues listed on Nasdaq Capital Market.
Company is evaluating options to maintain listing including potential reverse stock split.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

REVELATION BIOSCIENCES, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

August 8, 2023, Revelation Biosciences, Inc. (the “Company”) received a letter from the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company of its noncompliance with Nasdaq Listing Rule 5550(a)(2) (the “Rule”) by failing to maintain a minimum bid price for its common stock of at least $1.00 per share for 30 consecutive business days. According to the letter, the Company has a 180 calendar day grace period to regain compliance with the Rule (the “Grace Period”), subject to a potential 180 calendar day extension, as described below. To regain compliance, the Company’s common stock must have

View on SEC.gov

19 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

REVELATION BIOSCIENCES, INC. filing history →

Source: SEC EDGAR

accession 0000950170-23-041840

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.